A growing number of men over 40 are searching for “male menopause” because something feels different. Energy fades by mid-afternoon, sleep is lighter, libido is lower, and the body holds weight in ways it once did not.
The term itself is not clinically accurate, but the symptoms behind the search are often real and deserve serious attention. This article explains the misconception, describes what is happening physiologically, and then addresses a topic most content in this category avoids: the overdiagnosis and marketing pressure surrounding low testosterone in 2026. It is intended as a clinical clarification, not a scare piece or a sales pitch.
What Men Mean When They Say “Male Menopause”
The experiences men describe are consistent: persistent fatigue, reduced sex drive, low mood, poor concentration, loss of muscle tone, and disrupted sleep.
Men use the word “menopause” because it is the only widely known cultural shorthand for “my hormones are changing with age,” even though the biology does not match. These complaints have also been dismissed for years, by men themselves and sometimes by clinicians, as “just getting older.” That dismissal is part of why a borrowed label has taken hold.
The Clinical Truth: Why “Male Menopause” Is a Misnomer
The NHS calls “male menopause” an unhelpful and misleading term because it suggests a sudden drop in testosterone in middle age, similar to female menopause. Mayo Clinic and other health systems use more accurate terms: andropause, age-related low testosterone, late-onset hypogonadism, or androgen decline in the aging male (ADAM).
Even those terms are now being questioned. The Endocrine Society’s 2026 statement cautions that vague labels such as “age-related” or “late-onset” hypogonadism are difficult to define and blur the line between disease and normal aging.
Andropause vs. Menopause: The Biological Difference
Urologists describe the core distinction plainly: female menopause occurs over a finite, defined period, while testosterone decline in men is a gradual process that can span decades. Levels typically fall about 1% per year after age 40, and in some men the decline begins as early as the late 20s or early 30s.
Men have no equivalent to the ovaries’ finite reserve. Because the mechanisms are not parallel, the term “male menopause” misleads more than it explains.
Why Hot Flashes Are Rare in Men
Because testosterone declines gradually rather than abruptly, most men do not experience hot flashes. The exception is men receiving certain prostate cancer treatments that suppress hormones rapidly. Those men can have menopause-like hot flashes, but that is a separate clinical situation.
What Is Actually Happening: Andropause and Age-Related Low Testosterone
Low testosterone is common. The landmark Hypogonadism in Males (HIM) study estimated a prevalence of about 39% in men aged 45 and older. The rate rises with each decade:
- 50s: about 12%
- 60s: about 19%
- 70s: about 28%
- 80s: about 49%
Fewer than 10% of men under 50 have testosterone deficiency. The pattern is gradual and closely tied to age. It is not a universal midlife event.
The Symptoms Men Are Noticing, and Why They Are Real
The symptoms most often associated with low testosterone include:
- Difficulty sleeping
- Loss of muscle mass
- Low bone mineral density
- Low energy
- Mood swings
- Poor memory and concentration
- Reduced sexual desire and sexual dysfunction
There is an important qualification: only about 12% of men aged 40 to 70 with low testosterone experience symptoms from it. Mayo Clinic also notes that these symptoms are nonspecific. Obesity (a BMI of 30 or higher), sleep apnea, depression, thyroid dysfunction, and diabetes can all produce the same picture.
The symptoms are valid and worth investigating. Their cause, however, is not automatically testosterone. That is why a diagnosis requires more than a symptom checklist.
The Overdiagnosis Controversy: What the Low-T Industry Leaves Out
A large testosterone industry, driven by social media influencers, direct-to-consumer telehealth clinics, and aggressive advertising, is changing how men think about aging, energy, and masculinity. Prescriptions for testosterone replacement therapy have risen more than 30% over the past decade, and the market reached roughly $2.1 billion in 2025. Social media posts promoting testosterone have been linked to more than $400 million in U.S. testosterone therapy sales.
Reporting from NPR and academic analysis covered by News-Medical describe healthy men being persuaded they have a medical disorder they may not have. Red Mountain’s position is that men should be able to tell the difference between a real, correctable clinical finding and a diagnosis shaped by marketing.
Why Many Men With Low Testosterone Have No Symptoms
Data from the HIM study and the NIH show that most older men with low testosterone have no symptoms. A lab number without symptoms is not a diagnosis. Marketing that suggests otherwise does not reflect guideline-based medicine.
The Rebranding of Low-T Toward Younger Men
Low-T messaging used to target older men. It is now increasingly directed at active men in their 20s and 30s. As a result, younger men with normal, age-appropriate levels may be pushed toward unnecessary testing or treatment based on vague symptom lists rather than confirmed lab results.
The Guideline-Based Standard: How Low Testosterone Should Actually Be Diagnosed
The Endocrine Society’s 2026 standard requires two things: symptoms of decreased testosterone and consistently low, accurately measured total and free testosterone in blood tests. Age alone does not qualify, and neither does a checklist. The same standard applies to men of every age. There is no looser threshold for older men, which is one reason the Society discourages vague “age-related” labels.
Symptoms AND Labs, Not Either/Or
Diagnosis should rest on at least two separate early-morning, fasting testosterone tests, usually assessed against a common clinical threshold near 300 ng/dL. A single test, a symptom quiz, or an online questionnaire does not meet this standard. Testosterone levels vary across the day and from one day to the next, so one result taken in isolation can be misleading.
Ruling Out Other Causes First
Before diagnosing hypogonadism, clinicians should rule out reversible factors, including obesity and medications such as corticosteroids or opioids. When symptoms result from excess weight (a BMI above 27) and no other underlying cause is found, weight loss is the recommended first-line approach. Guidelines also advise against routinely prescribing testosterone to all men 65 and older based on low levels alone.
What Changed in 2025–2026: The Regulatory Shift Worth Knowing
In 2025, based on the TRAVERSE trial, the FDA removed the cardiovascular boxed warning from testosterone products and added a new warning about increased blood pressure. The agency kept “Limitation of Use” language for age-related hypogonadism, which indicates that regulators still treat it as distinct from clearly defined medical hypogonadism.
Later in 2026, the FDA signaled interest in revising eligibility so that men with low testosterone and low libido could qualify for treatment regardless of an identifiable underlying cause. This is a development worth watching, not settled policy. Regulatory changes can expand the options available, but they do not change the clinical principle of diagnosing before treating.
So, Is This You? A Framework for Thinking It Through
A self-diagnosis checklist is less useful than a structured way of reasoning through the question:
- Persistent symptoms that last for weeks or months, not occasional off days.
- Risk factors such as age, excess weight, sleep problems, or chronic conditions.
- Confirmed labs, with repeated morning tests interpreted in context.
Men in this situation should also consider whether poor sleep, depression, thyroid problems, or metabolic weight gain could explain how they feel. These conditions are common and frequently overlooked. The only reliable answer comes from accurate testing interpreted by a clinician.
How Red Mountain Approaches This Differently
At Red Mountain, hormone optimization belongs to the Function stage of care. Its purpose is to restore how the body works, including energy, sleep, mood, muscle, and cognition. It is not offered as a cosmetic or virility product.
The approach follows the guideline-based standard described above: symptoms plus confirmed lab work, not age or a checklist. Red Mountain provides in-person oversight at brick-and-mortar clinics and draws on more than 30 years of real-world patient outcomes. Its workup is designed to identify reversible contributors such as weight, sleep, and metabolic factors before treatment is considered. Medication is one tool within that process. The broader solution is clinical structure and ongoing support.
Conclusion: Respecting the Symptoms, Correcting the Term
“Male menopause” is not a real diagnosis. The fatigue, mood changes, and low libido that lead men to search for it are real and worth investigating. Useful answers come from accurate testing and a complete clinical picture, not from a label borrowed from female physiology or a marketing funnel that relies on insecurity. Understanding what is actually happening in the body is the first step, whatever the next step turns out to be.
Next Step: Getting a Clear, Guideline-Based Answer
For men who recognize these symptoms, a consult is usually the next step toward accurate labs and a clear clinical picture. Red Mountain clinicians explain the full picture in consults, including any reversible causes, before any discussion of hormone optimization begins. The aim is information and clarity, so that any decision is based on a confirmed diagnosis.
